Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors

Breast Cancer Research and Treatment

Volumn 58, Issue 1, 1999, Pages 1-10

  Hines, Susan J ^a,b   Litz, Julie S ^a   Krystal, Geoffrey W ^a  

^a HUNTER HOLMES MCGUIRE VA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Akt; Breast cancer; c kit; EGF; ERK; Heregulin; Stem cell factor

Indexed keywords

BLOCKING ANTIBODY; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; BREAST NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; NEUREGULIN-1; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033457944     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006272527435     Document Type: Article

References (42)

1. 1. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, and Ullrich A: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6: 3341-3351, 1987
2. 2. Zsebo KM, Williams D, Geissler E, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC: Stem cell factor is encoded at the S/locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213-224, 1990
3. 3. Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P: Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice -evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3: 816-826, 1989
4. 4. Russell ES: Hereditary anemias of the mouse: a review for geneticists. Adv Genet 20: 357-459, 1979
5. 5. Lassam N, Bickford S: Loss of c-kit expression in cultured melanoma cells. Oncogene 7: 51-56, 1992
6. 6. Wang C, Curtis J, Geissler E, McCulloch E, Minden M: The expression of the proto-oncogene c-kit in the blast cells of acute myeloblastic leukemia. Leukemia 3: 699-702, 1989
7. 7. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin JD: Expression and functional role of the protooncogene c-kit in acute myeloblastic leukemia cells. Blood 78: 2962-2968, 1991
8. 8. Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam M, Ludwig WD, Zsebo K, Welte K: Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 80: 1199-1206, 1992
9. 9. Strohmeyer T, Peter S, Hartmann M, Munemitsu M, Ackermann R, Ullrich A, Slamon DJ: Expression of the hst-1 and c-kit proto-oncogenes in human testicular germ cell tumors. Cancer Res 51: 1811-1816, 1991
10. 10. Plummer H III, Catlett J, Leftwich J, Armstrong B, Carlson P, Huff T, Krystal G: c-myc expression correlates with suppression of c-kit proto-oncogene expression in small cell lung cancer cell lines. Cancer Res 53: 4337-4342, 1993
11. 11. Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T: Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6: 2291-2296, 1991
12. 12. Rygaard K, Nakamura T, Spang-Thomsen M: Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor in SCLC cell lines and xenografts. Br J Cancer 67: 37-46, 1993
13. 13. Natali P, Nicotra M, Sures I, Santoro E, Bigotti A, Ullrich A: Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52: 6139-6143, 1992
14. 14. Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Sugiura T, Ariyoshi Y, Takahashi T: Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Path 142: 339-346, 1993
15. 15. Hines SJ, Organ C, Kornstein MJ, Krystal, GW: Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Diff 6: 769-779, 1995
16. 16. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92: 10560-10564, 1995
17. 17. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad TG, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279: 577-580, 1998
18. 18. Moskaluk CA, Tian Q, Marshall CR, Rumpel, Franquemont DW, Frierson HF Jr: Mutation of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene 18: 897-902, 1999
19. 19. Tian Q, Frierson HF, Krystal GW, Moskaluk, CA: Activating c-kit gene mutations in human germ cell tumors. Am J Path, 1999 (in press)
20. 20. McNicce I, Langley K, Zsebo K: Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3, and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19: 226-231, 1991
21. - cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77: 2316-2321, 1991
22. 22. Carow C, Hangoc G, Cooper S, Williams D, Broxmeyer H: Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with high replating potential. Blood 78: 2216-2221, 1991
23. 23. Sainsbury J, Farndon J, Needham G, Malcolm A, Harris A: Epidermal-growth-factor receptor status as a predictor of early recurrence of and death from breast cancer. Lancet 1: 1398-1402, 1987
24. 24. Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987
25. 25. Bacus S, Zelnick C, Plowman G, Yarden Y: Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers: implication for tumor biology and clinical behavior. Am J Clin Path 102(Suppl 1): S13-S24, 1994
26. 26. Goldman R, Levy RB, Peles E, Yarden Y: Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochem 29: 11024-11028, 1990
27. 27. Wada T, Qian X, Greene MI: Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61: 1339-1347, 1990
28. 28. Earp HS, Dawson TL, Li X, Yu H: Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35: 115-132, 1995
29. 29. Wallasch C, Weiss FU, Niederfellner G, Jallal B, Issing W, Ullrich A: Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J 14:4267-4275, 1995
30. erbB4. Nature 366: 473-475, 1993
31. 31. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York, 1989
32. 32. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 64: 281-302, 1991
33. 33. Nishida K, Tsukamoto T, Uchida K, Takahashi T, Takahashi T, Ueda R: Introduction of the c-kit gene leads to growth suppression of a breast cancer cell line, MCF7. Anticancer Res 16: 3397-3402, 1996
34. 34. Hayman MJ, Meyer S, Martin F, Steinlein P, Beug H: Selfrenewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGFα-erbB and SCF/c-kit receptors. Cell 74: 157-169, 1993
35. v bone marrow cells by ectopic expression of normal and mutant epidermal growth factor receptors. Blood 82: 1463-1470, 1993
36. 36. Herbst R, Lammers R, Schlessinger J, and Ullrich A: Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase. J Biol Chem 266: 19908-19916, 1991
37. ras GTPase-activating protein. Proc Natl Acad Sci USA 89: 1587-1591, 1992
38. 38. Rottapel R, Reedijk M, Williams DE, Lyman SD, Anderson DM, Pawson T, Bernstein A: The steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signalling proteins is induced by the steel factor. Mol Cell Biol 11: 3043-3051, 1991
39. 39. Miyazawa K, Hendrie PC, Mantel C, Wood K, Ashman LK, Broxmeyer HE: Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase. Exp Hematol 19: 1110-1123, 1991
40. 40. Lev S, Givol D, Yarden Y: A specific combination of substrates is involved in signal transduction by the kit-encoded receptor. EMBO J 10:647-654, 1991
41. 41. Lev S, Givol D, Yarden Y: The interkinase domain of Kit contains the binding site for phosphatidylinositol 3′ kinase. Proc Natl Acad Sci USA 89: 678-682, 1992
42. 42. Boonstra J, Rijken P, Humbel B, Cremers F, Verkleij A, Van Bergen en Henegouwen P: The epidermal growth factor. Cell Biol Intl 19: 413-430, 1995